IVREA PHARMACEUTICALS
Ivrea Pharmaceuticals is a specialty pharmaceutical company, provides clinical development and commercialization of prescription pharmaceuticals for the treatment of dermatologic conditions, such as onychomychosis, acne, and photodamage.
IVREA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Quincy, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(617)376-2491
Email Addresses:
[email protected]
Total Funding:
5.1 M USD
Similar Organizations
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Current Employees Featured
Founder
More informations about "IVREA Pharmaceuticals"
IVREA Pharmaceuticals - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 5, 2005: Series A - IVREA …See details»
IVREA Pharmaceuticals - Products, Competitors, …
IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic …See details»
Ivrea Pharmaceuticals Inc - Company Profile and News
Company profile page for Ivrea Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Ivrea Pharmaceuticals, Inc. Company Profile | Medfield, MA ...
Pharmaceutical and Medicine Manufacturing Chemical Manufacturing Manufacturing Printer Friendly View Address: 6 Loeffler Ln Medfield, MA, 02052-3143 United StatesSee details»
IVREA Pharmaceuticals Announces Formation Of New …
QUINCY, Mass., Feb. 1 /PRNewswire/ -- Ivrea Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company focused on developing and commercializing novel treatments for …See details»
Daniel Lynch - CEO @ IVREA Pharmaceuticals - Crunchbase
Primary Organization . IVREA Pharmaceuticals . Gender Male; Jobs. Edit Jobs Section. Number of Current Jobs 1. Daniel Lynch is the CEO at IVREA Pharmaceuticals. IVREA …See details»
IVREA raises $11M for clinical development
Jul 9, 2006 IVREA raises $11M for clinical development. ivrea, raises, 11m, clinical, development, massachusetts, usa-based. Wednesday 13 November 2024. About. Contact. …See details»
Ivrea Pharmaceuticals Inc. - BioCentury Company Profiles
Ivrea Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
IVREA Pharmaceuticals Stock Price, Funding, Valuation, …
See IVREA Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on IVREA Pharmaceuticals's post-money valuation and revenue.See details»
IVREA Pharmaceuticals Raises $11 Million For Clinical
Jun 30, 2006 IVREA Pharmaceuticals is developing products having significant medical and patient advantages in the treatment of onychomycosis and acne. The company has offices in …See details»
IVREA Pharmaceuticals - CB Insights
Compare IVREA Pharmaceuticals to Competitors. F. Frio Pharmaceuticals. Frio Pharmaceuticals is dedicated to oral-systemic health and was spun out of Biomedical Development Corporation …See details»
C&L: Ivrea taps Daniel Lynch for top job - Fierce Biotech
Feb 6, 2007 Ivrea Pharmaceuticals has named Daniel S. Lynch as president and CEO. Lynch spent nearly five years at ImClone Systems as both CFO and CEO. AM-Pharma has named …See details»
IVREA Pharmaceuticals Appoints Daniel S. Lynch As …
QUINCY, Mass., Feb. 1 /PRNewswire/ -- Ivrea Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company focused on developing and commercializing novel treatments for …See details»
IVREA Pharmaceuticals - Contacts, Employees, Board …
Organization. IVREA Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... We're working on getting contact data for …See details»
IVR 103 - AdisInsight - Springer
Ivrea Pharmaceuticals was developing a topical formulation of tretinoin using their proprietary technology platform with the aim of producing a topical IVR 103 - AdisInsight Either you have …See details»
ICE GROUP acquires ABC Farmaceutici S.p.A. - News
Dec 16, 2021 We are pleased to announce that on December 15 th ICE Pharma completed the acquisition of ABC Farmaceutici S.p.A. (“ABC”). ABC is a pharmaceutical company based in …See details»
IVREA Pharmaceuticals Announces Successful In Vitro …
QUINCY, Mass., Feb. 2 /PRNewswire/ -- Ivrea Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company focused on developing and commercializing novel treatments for …See details»
Novartis provides update on production of radioligand …
Basel, May 5, 2022 — Novartis today announced a temporary, voluntary suspension of production at its radioligand therapy production sites in Ivrea, Italy and Millburn, New Jersey. The …See details»
IVREA Pharmaceuticals - Tech Stack, Apps, Patents
Organization. IVREA Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit …See details»
WHO calls for stronger surveillance of H5N1 bird flu among …
1 day ago A World Health Organization official on Thursday called for stronger surveillance in animals for evidence of infection with H5N1 bird flu in order to curb its spread.See details»